Company intelligence / Profile preview

The Benchmark Company

New York City, New York, United Statesbenchmarkcompany.com ↗

Ownership: Private
Development stage: Preclinical

Overview

The Benchmark Company is an institutionally focused research, sales & trading, and investment banking firm covering multiple sectors, including biotechnology and healthcare. They have been active in biotechnology investment banking, having acted as sole book running manager for offerings such as Seelos Therapeutics and joint book running manager for Fortress Biotech.[5]

Industry: Consulting

Drug pipeline

3 assets

CTM-N2D

Phase 1

Indications: Solid tumors, Hematological malignancies

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on The Benchmark Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Benchmark Company.

Explore the full profile